| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Operating Officer
1 company
Deschatelets Pascal is a Chief Scientific Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $48.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $63.79 | $765,480.00 | -1.2% | +40.8% | -3.6% | |
| Feb 8, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $54.45 | $653,400.00 | -1.2% | +71.1% | +30.3% | |
| Jan 9, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $46.08 | $552,960.00 | -1.2% | +65.5% | +52.0% | |
| Dec 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $47.50 | $570,000.00 | -1.2% | +28.6% | +24.6% | |
| Nov 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $46.47 | $557,640.00 | -1.2% | +17.2% | -0.3% | |
| Oct 10, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $57.50 | $690,000.00 | -1.2% | -17.7% | -23.3% | |
| Sep 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $63.98 | $767,760.00 | -1.2% | -30.7% | -39.3% | |
| Aug 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $62.50 | $750,000.00 | -1.3% | -23.6% | -61.3% | |
| Jul 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $47.95 | $575,400.00 | -1.3% | +20.7% | +75.8% | |
| Jun 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $44.09 | $529,080.00 | -1.3% | +32.3% | +105.6% |